Common Contracts
8 similar Executive Retention Agreement contracts by Myriad Genetics Inc
Executive Retention AgreementExecutive Retention Agreement • February 7th, 2020 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and ________________________ (the “Executive”), is made as of ________________________, (the “Effective Date”).
Executive Retention AgreementExecutive Retention Agreement • November 7th, 2018 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and ________________________ (the “Executive”), is made as of ___________, (the “Effective Date”).
MYRIAD GENETICS, INC. Executive Retention AgreementExecutive Retention Agreement • November 2nd, 2016 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Virginia C. Drosos (the “Executive”), is made as of September 26, 2016 (the “Effective Date”).
MYRIAD GENETICS, INC. Executive Retention AgreementExecutive Retention Agreement • November 4th, 2015 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is made as of , (the “Effective Date”).
MYRIAD GENETICS, INC. Executive Retention AgreementExecutive Retention Agreement • February 4th, 2015 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and R. Bryan Riggsbee (the “Executive”), is made as of December 18, 2014 (the “Effective Date”).
MYRIAD GENETICS, INC. Form of Executive Retention AgreementExecutive Retention Agreement • May 5th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is made as of February 17, 2005 (the “Effective Date”).
MYRIAD GENETICS, INC. Executive Retention AgreementExecutive Retention Agreement • February 6th, 2007 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Mark C. Capone (the “Executive”), is made as of November 17, 2006 (the “Effective Date”).
MYRIAD GENETICS, INC. Form of Executive Retention AgreementExecutive Retention Agreement • May 4th, 2005 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
THIS EXECUTIVE RETENTION AGREEMENT (this "Agreement"), by and between Myriad Genetics, Inc., a Delaware corporation (the "Company"), and (the "Executive"), is made as of February 17, 2005 (the "Effective Date").
